[1] Narrow-band imaging: a novel screening tool for early nasopharyngeal carcinoma

[2] Radiomic machine-learning classifiers for prognostic biomarkers of advanced nasopharyngeal carcinoma

[3] Osteopontin expression in nasopharyngeal carcinoma: Its relevance to the clinical stage of the disease

[4] Intensity-modulated carbon-ion radiation therapy versus intensity-modulated photon-based radiation therapy in locally recurrent nasopharyngeal carcinoma: a dosimetric comparison

[5] Intensity-modulated carbon-ion radiation therapy versus intensity-modulated photon-based radiation therapy in locally recurrent nasopharyngeal carcinoma: a dosimetric comparison

[6] Intensity-modulated carbon-ion radiation therapy versus intensity-modulated photon-based radiation therapy in locally recurrent nasopharyngeal carcinoma: a dosimetric comparison

[7] Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.

[8] Plasma microRNA expression signature involving miR-548q, miR-630 and miR-940 as biomarkers for nasopharyngeal carcinoma detection.

[9] No association between olymorphism and risk of nasopharyngeal carcinoma

[10] Association of regenerating gene 1A single-nucleotide polymorphisms and nasopharyngeal carcinoma susceptibility in southern Chinese population.

[11] Analysis of nasopharyngeal carcinoma risk factors with Bayesian networks.

[12] Chinese nonmedicinal herbal diet and risk of nasopharyngeal carcinoma: A population-based case-control study.

[13] Risk of developing sudden sensorineural hearing loss in patients with nasopharyngeal carcinoma: A population-based cohort study

[14] Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.

[15] Upregulation of lncRNA HAGLROS enhances the development of nasopharyngeal carcinoma via modulating miR-100/ATG14 axis-mediated PI3K/AKT/mTOR signals

[16] Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.

[17] Publisher Correction: NOS1 S-nitrosylates PTEN and inhibits autophagy in nasopharyngeal carcinoma cells (Cell Death Discovery, (2017), 3, (17011), 10.1038/cddiscovery.2017.11)

[18] Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma

[19] Impact of cumulative cisplatin dose and adjuvant chemotherapy in locally-advanced nasopharyngeal carcinoma treated with definitive chemoradiotherapy.

[20] Effect of COVID-19 Epidemic on Delay of Diagnosis and Treatment Path for Patients with Nasopharyngeal Carcinoma.

[21] Narrow-band imaging: a novel screening tool for early nasopharyngeal carcinoma

[22] Endoscopic nasopharyngectomy for salvage in nasopharyngeal carcinoma: a novel anatomic orientation

[23] Chemotherapy and chemo-resistance in nasopharyngeal carcinoma

[24] Radiomic machine-learning classifiers for prognostic biomarkers of advanced nasopharyngeal carcinoma

[25] clinical implications of plasma epstein–barr virus dna in children and adolescent nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy

[26] nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma

[27] induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage t3-4 nasopharyngeal carcinoma

[28] radiosensitization effect of nedaplatin on nasopharyngeal carcinoma cells in different status of epstein-barr virus infection

[29] orbital metastasis as the primary presentation of nasopharyngeal carcinoma

[30] use of taxane-containing induction chemotherapy in combination with concurrent chemoradiotherapy in chinese patients with locally advanced nasopharyngeal carcinoma: a meta-analysis

[31] identify the radiotherapy-induced abnormal changes in the patients with nasopharyngeal carcinoma

[32] a glucosamine-specific lectin from green dragon no. 8 beans (phaseolus vulgaris) induced apoptosis on nasopharyngeal carcinoma cells

[33] nrp-1 gene expression in nasopharyngeal carcinoma tissue and regulating effect of targeted inhibition of gene expression on cell function

[34] therapeutic implications of epstein–barr virus infection for the treatment of nasopharyngeal carcinoma

[35] combined upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 predicts unfavorable prognosis in human nasopharyngeal carcinoma

[36] epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma

[37] Osteopontin expression in nasopharyngeal carcinoma: Its relevance to the clinical stage of the disease

[38] Retraction Note: Proteomic analysis on N, N′-dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma 6-10B cells(BMC Biochem, (2015), 13, (25 ), 10.1186/1471-2091-13-25)